Attention-Deficit Hyperactivity Disorder (ADHD) Rating Scale and Epilepsy
NCT ID: NCT01482026
Last Updated: 2025-09-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
173 participants
INTERVENTIONAL
2011-11-30
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In these conditions, our study was designed to estimate the sensitivity to changes of the different sub-scores of the ADHD rating Scale IV (ADHD RS IV) in epileptic patient. This will then optimize our methodological approach for a therapeutic trial.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Relationship of Epilepsy and Attention Deficit Hyperactive Disorder
NCT03806946
Prevalence of ADHD in Children With Epilepsy
NCT07205211
MRI Investigations in Attention Deficit Hyperactivity Disorder (ADHD) and High Potential (HP) Children for a Better Therapeutic Approach
NCT02823782
Clinical Efficacy and Long Term Effects of Transcranial Direct Current Stimulation (tDCS) in Children With Attention Deficit/Hyperactivity Disorder (ADHD)
NCT04704687
Brain Activity Associated With Inhibition of Action in Attention-deficit
NCT04768556
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treated patients
Patients for whom ADHD treatment is introduced at enrolment. Evolution of the ADHD Rating Scale-IV inattention subscore
ADHD Rating Scale-IV
ADHD Rating Scale-IV test
Non treated patients
Patients for whom no ADHD treatment is required at enrolment. Evolution of the ADHD Rating Scale-IV inattention subscore
ADHD Rating Scale-IV
ADHD Rating Scale-IV test
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ADHD Rating Scale-IV
ADHD Rating Scale-IV test
ADHD Rating Scale-IV
ADHD Rating Scale-IV test
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* male or female;
* with a diagnosis of ADHD : predominantly inattentive or combined hyperactive-impulsive and inattentive according to the DSM IV criteria;
* children who agreed to participate to the protocol and whose legal representatives have clearly expressed their non-opposition to participate.
Exclusion Criteria
* with a diagnosis of ADHD predominantly hyperactive-impulsive subtype ADHD according to the DSM IV criteria;
* mental retardation defined by a score \< 70 at the verbal comprehension index and the perceptual reasoning score of the Wechsler Intelligence Scale for Children - Fourth Edition (WISC-IV)
* established diagnosis of any psychiatric co-morbidity other than ADHD according to the DSM IV criteria (pervasive developmental disorders including autism, bipolar disorder, psychotic disorder).
6 Years
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sylvain RHEIMS, MD
Role: PRINCIPAL_INVESTIGATOR
Service de Neurologie Fonctionnelle et Epileptologie, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de Neurologie pédiatrique, CHU d'Amiens
Amiens, , France
Service de Neurologie Pédiatrique, CHU d'Angers
Angers, , France
Service de Neurologie pédiatrique, CHU de Besançon
Besançon, , France
Unité de Neurologie de l'Enfant et de l'Adolescent, Hôpital Pellegrin
Bordeaux, , France
Institut des Epilepsies de l'Enfant et de l'Adolescent, Hôpital Femme Mère Enfant
Bron, , France
Service de Neurologie Fonctionnelle et Epileptologie, Hôpital Neurologique Pierre Wertheimer
Bron, , France
Service d'épileptologie pédiatrique, CHR de Chambéry
Chambéry, , France
Cabinet Médical du Dr ISNARD
Lyon, , France
Service de Neurologie pédiatrique, Hôpital de la Timone
Marseille, , France
Service de Neurologie Pédiatrique, Hôpital Robert-Debré
Paris, , France
Service de Neurologie pédiatrique, Hôpital Neckert-Enfants malades
Paris, , France
Service de Pédiatrie, Hôpital Sud
Rennes, , France
Centre Référent des Epilepsies Rares, Hôpital de Hautepierre
Strasbourg, , France
Service de Neurologie Pédiatrique, Hôpital des Enfants
Toulouse, , France
Service de Neurologie Pédiatrique, CHU de Tours
Tours, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Mercier C, Roche S, Gaillard S, Kassai B, Arzimanoglou A, Herbillon V, Roy P, Rheims S. Partial validation of a French version of the ADHD-rating scale IV on a French population of children with ADHD and epilepsy. Factorial structure, reliability, and responsiveness. Epilepsy Behav. 2016 May;58:1-6. doi: 10.1016/j.yebeh.2016.02.016. Epub 2016 Mar 15.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011.682/25
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.